RADICAVA ORS gives people with ALS an oral treatment option that offers the same efficacy as the IV formulation of edaravone1 JERSEY CITY, N.J., June 15, 2022 — Mitsubishi Tanabe …
Tag:
(edaravone)
-
-
Analysis Suggests Use of RADICAVA IV is Associated with Improved Survival in People with ALS JERSEY CITY, N.J., April 4, 2022 — Mitsubishi Tanabe Pharma America, Inc. (MTPA) today …